EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy (“dying back”): a clinical-neuropathological study

Jianguo Liu, Kailee Ong, Alex Meng, Gorazd B Stokin, Jeffrey A Loeb, John Ravits, Fei Song iD

Acta Neuropathologica · 2026

DOI: 10.1007/s00401-026-03072-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Jianguo Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neurons, Axons, Pyramidal Tracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, UCSD Microscopy Core grant, Target ALS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hallmark neuropathological feature of upper motor neuron (UMN) degeneration in amyotrophic lateral sclerosis (ALS) is the “sclerosis” of the lateral corticospinal tract (CST)—the major axonal pathway connecting UMNs to lower motor neurons (LMNs). However, few studies since Charcot’s original descriptions in the nineteenth century have directly correlated clinical UMN phenotypes with corresponding neuropathological findings. We examined the pathology of the lateral CST at the cervical, thoracic, and lumbar levels of the spinal cord from ALS patients with predominantly UMN (UMN-p) phenotypes and compared it with that in patients with predominantly LMN (LMN-p) phenotypes. We assessed myelin loss, axonal degeneration, neuroinflammation, and TDP-43 pathology. Spinal cords from UMN-p ALS cases exhibited pronounced myelin loss in the lateral CST compared to LMN-p cases and controls, consistent with clinical phenotyping. Quantitative analysis revealed significant axonal loss across all axon diameter ranges in UMN-p ALS, which was more severe than in LMN-p ALS. Importantly, axonal loss was more pronounced in the lumbar than in the cervical spinal cord. We identified a distinct population of foamy, inflammatory microglia localized to regions of severe myelin and axonal loss in UMN-p ALS. TDP-43 was measurably increased in the UMN axons of the lateral and ventral CSTs. In summary, “lateral sclerosis” of ALS correlates to clinically imputed UMN degeneration. It consists of a combination of myelin loss, distal greater than proximal axonal degeneration, inflammatory microglial activation within the CSTs, and abnormally increased axonal TDP-43. The length-dependent gradient of motor axonal loss supports a "dying-back" process. A detailed comparison of “dying-forward” and “dying-forward” is provided in the Discussion. The association of loss of axons and myelin with abnormal microglial activity shows glio-axonal interactions in UMN axon degeneration, the latter CST (lateral sclerosis) across all three spinal cord levels in the ALS UMN-p samples but does not establish a causal relationship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMotor NeuronsAxonsPyramidal TractsHumansFemaleMaleMiddle AgedAgedSpinal CordDNA-Binding ProteinsNerve DegenerationMyelin SheathAdult

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisAxon neurodegenerationCorticospinal tractsDying backMyelin lossNeuroinflammation

Substanzen

DNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA.
  • ALS and Neuromuscular Translational Research University of California, San Diego, CA, 92093, USA.
  • Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
  • Department of Neurology, Gloucestershire Royal Hospital, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
  • ALS and Neuromuscular Translational Research University of California, San Diego, CA, 92093, USA. jravits@health.ucsd.edu.
  • Department of Neurology and Rehabilitation, The University of Illinois at Chicago, NPI North Bldg., Room 174N, M/C 796, 912 S. Wood Street, Chicago, IL, 60612, USA. feisong@uic.edu.

ORCID-Profile: Fei Song

Förderung

  • NINDS NIH HHS
  • UCSD Microscopy Core grant
  • Target ALS
  • Startup Fund (F.S.) funded by the Department of Neurology and Rehabilitation of the University of Illinois at Chicago
  • AYZ Family Foundation
  • AKG global Foundation

Zitieren

APA

Liu, J., Ong, K., Meng, A., Stokin, G. B., Loeb, J. A., Ravits, J., & Song, F. (2026). Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy (“dying back”): a clinical-neuropathological study. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03072-9

Vancouver

Liu J, Ong K, Meng A, Stokin GB, Loeb JA, Ravits J, et al. Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy (“dying back”): a clinical-neuropathological study. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-03072-9

BibTeX
@article{Liu2026,
  author = {Liu, Jianguo and Ong, Kailee and Meng, Alex and Stokin, Gorazd B and Loeb, Jeffrey A and Ravits, John and Song, Fei},
  title = {Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy (“dying back”): a clinical-neuropathological study},
  journal = {Acta Neuropathologica},
  year = {2026},
  doi = {10.1007/s00401-026-03072-9}
}
Kostenlos starten →